The study of vancomycin use and its adverse reactions associated to patients of a brazilian university hospital

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Marinho, Daniel ^a,b   Huf, Gisele ^b   Ferreira, Bruno La ^c   Castro, Helena ^c   Rodrigues, Carlos R ^a   De Sousa, Valeria P ^a   Cabral, Lúcio M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Oswaldo Cruz Foundation   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 80052267236     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-236     Document Type: Article

References (31)

1. Vancomycin: Renewed interest in an old drag. Farber BB, Eur J Clin Microbiol 1984 3 1 10.1007/BF02032805 6705767
2. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Farber B, Moellering RC, Antimicrob Agents Chemother 1983 23 138 141 6219616 (Pubitemid 13168423)
3. Vancomycin-induced thrombocytopenia. Zenon GJ, Cadle RM, Hamill RJ, Arch Intern Med 1991 151 995 996 10.1001/archinte.151.5.995 2025149
4. Vancomycin-induced thrombocytopenia in a 60-year-old man: a case report. Shah RA, Musthaq A, Khardori N, J Med Case Reports 2009 3 7290 7294 10.4076/1752-1947-3-7290 19830166
5. Toxic epidermal necrolysis due to vancomycin. Vidal C, Gonzalez Quintela A, Fuente R, Ann Allergy 1992 68 345 347 1558331
6. Vancomycin-induced neutropenia resolves after substitution with teicoplanin. Sanche SE, Dust WN, Shevchuk YM, Clin Infect Dis 2000 31 824 825 10.1086/314028 11017842 (Pubitemid 32295514)
7. Uncommon vancomycin: induced side effects. Rocha JL, Kondo W, Baptista MI, Da Cunha CA, Martins LT, Braz J Infec Dis 2002 6 196 200 10.1590/S1413-86702002000400007
8. An elderly woman with 'Red Man Syndrome' in association with oral vancomycin therapy: a case report. Bailey P, Gray H, Cases J 2008 1 111 113 10.1186/1757-1626-1-111 18710566
9. Gilman A, Limbird L, Hardman J, Goodman & Gilman's:The Pharmacological Basis of Therapeutics New York: McGraw-Hill Professional 2001 21764749
10. Red man syndrome: incidence, etiology, and prophylaxis. Wallace MR, Mascola JR, Oldfield EC, J Infect Dis 1991 164 1180 1185 10.1093/infdis/164.6. 1180 1955716
11. Emergence of VanB phenotype-vanA genotype in vancomycin resistant enterococci in Brazilian hospital. Zanella RC, Lima MDJC, Tegani LS, Hitomi A, Brandileone MCC, Palazzo ICV, et al. Braz J Microbiol 2006 37 117 118 (Pubitemid 43793986)
12. The comparative efficacy and safety of vancomycin vs. teicoplanin: Systematic review and meta-analysis. Svetitsky S, Leibovici L, Paul M, Antimicrob Agents Chemother 2009 53 4069 4079 10.1128/AAC.00341-09 19596875
13. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Rybak M, Lomaestro B, Rotschafer JC, Moellerin R, Craig W, Billeter M, et al. Am J Health Syst Pharm 2009 66 82 98 10.2146/ajhp080434 19106348
14. Adverse drug reactions: A critical review. Karch FE, Lasagna L, JAMA 1975 234 1236 1241 10.1001/jama.234.12.1236 1242749
15. A method for estimating the probability of adverse drug reactions. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. Clin Pharmacol Ther 1981 30 239 245 10.1038/clpt.1981.154 7249508 (Pubitemid 12149145)
16. Adverse drug reactions. Naranjo CA, Shear NH, Busto U, Principles of medical pharmacology Oxford University Press: New York, Kalant H, Roschlau WHE, 6 1998 791 800
17. A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient. Vance-Bryan K, Rotschafer JC, Gilliland SS, Rodvold KA, Fitzgeralg CM, Guay DRP, J Antimicrob Chemother 1994 33 811 821 10.1093/jac/33.4.811 8056700 (Pubitemid 24149817)
18. Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination. Goetz MB, Sayers J, J Antimicrob Chemother 1993 32 325 334 10.1093/jac/32.2.325 8226435 (Pubitemid 23272318)
19. Nephrotoxicity of vancomycin, alone and with an aminoglycoside. Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH, J Antimicrob Chemother 1990 25 679 687 10.1093/jac/25.4.679 2351627 (Pubitemid 20167292)
20. Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions. Healy DP, Sahai JV, Fuller SH, Polk RE, Antimicrob Agents Chemother 1990 34 550 554 1693055 (Pubitemid 20122281)
21. Castro LLC, Fundamentos de Farmacoepidemiologia Sao Paulo: Grupuram 2000
22. Bauer L, Applied Clinical Pharmacokinetics New York: McGraw-Hill Medical 2001
23. Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin. Rybak MJ, Bailey EM, Warbasse LH, Antimicrob Agents Chemother 1992 36 1204 1207 1384423
24. Safety and efficacy of glycopeptide antibiotics. Finch RG, Eliopoulos GM, J Antimicrob Chemother 2005 55 i5 13 10.1093/jac/dki004 15750036 (Pubitemid 40425473)
25. A retrospective drug utilization evaluation of vancomycin usage in paediatric patients. Hing WC, Bek SJ, Lin RT, Li SC, J Clin Pharm Ther 2004 29 359 365 10.1111/j.1365-2710.2004.00571.x 15271103 (Pubitemid 39062166)
26. Vancomycin-induced immune thrombocytopenia. Von DA, Curtis BR, Bougie DW, McFarland JG, Ahl S, Limbu I, et al. N Engl J Med 2007 356 904 910 10.1056/NEJMoa065066 17329697 (Pubitemid 46339909)
27. Economic aspects of antibacterial adverse effects. Beringer PM, Wong-Beringer A, Rho JP, PharmacoEcon 1998 13 35 49 10.2165/00019053-199813010- 00004 (Pubitemid 28033989)
28. Influence of antihistamine pretreatment on vancomycin-induced red-man syndrome. Sahai J, Healy DP, Garris R, Berry A, Polk RE, J Infect Dis 1989 160 876 881 10.1093/infdis/160.5.876 2572652 (Pubitemid 19266845)
29. Prediction of creatinine clearance from serum creatinine. Cockcroft DW, Gault MH, Nephron 1976 16 31 41 10.1159/000180580 1244564
30. Predictive performance of a vancomycin-aminoglycoside population model. Beringer PM, Wong-Beringer A, Rho JP, Ann Pharmacother 1998 32 176 181 10.1345/aph.17129 9496400 (Pubitemid 28082327)
31. Multivariate analysis used in the investigation of antimicrobials. Maldonado FH, Revista espanola de quimioterapia publicacion oficial de la Sociedad Espanola de Quimioterapia 2007 20 300 309 18080026